Gestational Diabetes and Intrauterine Growth Restriction

Dear Colleagues,

Intrauterine growth restriction and gestational diabetes are two of the most common pathologic entities encountered during the antenatal period and account for approximately 10-15% of pregnancies. Gestational diabetes is a significant risk factor that predisposes patients to intrauterine fetal growth restriction through a variety of pathophysiological processes,  examples of which include epigenetic alterations, impaired cholesterol metabolism, placental vasculopathy, etc. Significant advances have been achieved in the last decade; however, research is still needed to elucidate the pathophysiology of both pregnancy complications in order to help achieve optimal maternal and neonatal antenatal outcomes.

In the present issue, we hope that leading experts will share their perspectives on the pathophysiology of gestational diabetes and intrauterine growth restriction and that they will contribute to current knowledge with novel evidence that provides the foundation for further research.

We seek contributions in the form of original research articles, reviews, or shorter perspective articles on all aspects related to the subject. Topics may include but are not limited to epigenetic and genetic modifications, altered protein profiles, ultrasonographic markers, and environmental factors that predispose patients to the occurrence of gestational diabetes and/or intrauterine growth restriction.

Dr. Vasilios Pergialiotis
Prof. Dr. George Daskalakis
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.